A Review on Transdermal Drug Delivery through Patches
Article Sidebar
Main Article Content
Abstract
The goal of a transdermal drug delivery system (TDDS), which belongs to the controlled drug delivery category, is to distribute medications via the skin at a set and regulated rate. Extended therapeutic impact, fewer side effects, higher bioavailability, improved patient adherence, and easy medication termination are just a few advantages of this strategy. The stratum corneum, the skin's outermost layer, is crucial in regulating the transdermal entry of the majority of drugs. Drug penetration is facilitated by three primary pathways: intercellular, transcellular, and appendageal. It is crucial to take into account a variety of aspects while delivering medications via this route, such as the skin's age and health, physicochemical characteristics, and environmental impacts. A polymer matrix, membrane, drug, penetration enhancers, pressure-sensitive adhesives, backing laminates, and a release liner are essential components of Transdermal Drug Delivery Systems (TDDS). Reservoir systems, matrix systems, and micro-reservoir systems are some of the types of transdermal patches that are specifically designed to deliver active chemicals into the circulatory system through the skin. Stability, in vitro drug release, and adhesion characteristics are all assessed using a standardized method. The goal of studying the subject of transdermal drug delivery systems using patches is to thoroughly assess the developments, difficulties, and possible uses of this cutting-edge drug delivery technique.
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Pan-African Journal of Health and Psychological Sciences (PAJHPS) are open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Under this license:
-
Authors retain copyright and grant the journal the right of first publication.
-
The work may be shared, copied, redistributed, and adapted for any purpose, even commercially.
-
Appropriate credit must be given to the original author(s) and the journal, along with a link to the license.
-
Users must indicate if changes were made.
-
There are no restrictions on reuse, provided the original work is properly cited.
Citation:
Authors and users must cite the original work in the following manner:
Author(s). (Year). Title of the article. Pan-African Journal of Health and Psychological Sciences, Volume(Issue), page range. https://doi.org/xx.xxxx/pajhps.vXnY.xxx
Copyright Statement:
Authors grant PAJHPS a non-exclusive license to publish the work and identify itself as the original publisher. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version (e.g., post it to a repository or publish it in a book), with acknowledgment of its initial publication in this journal.
How to Cite
References
1. Allen L, Popovich N, CH. Ansel. Pharmaceutical dosage forms and drug delivery systems, 8th Edn.2005.
2. Kumar P, Sankar C, Mishra B. Delivery of macromolecules through skin. Indian Pharm. 2004;5(3):7-17.
3.OAH, Khan H, Sarfraz M, MA, Ijaz S, Hameed A. Transdermal patches: Design and current approaches to painless drug delivery. Acta Pharm. 2019;69(2):197-15
4. Zhang Y, Yu J, Kahkoska A, Wang J, Buse JB, Gu Z. Advances in transdermal insulin delivery. Adv Drug Deliv Rev. 2019;139:51-70
5. Vos PD, Faas M, Spasojevic M, Sikkema J. Encapsulation for preservation of functionality and targeted delivery of bioactive food components. Int Dairy J. 2010;20(4):292-302.
6. Heifer P, Shultz T. Coupled feedback loops maintain synaptic long-term potentiation: A computational model of PKMzeta synthesis and AMPA receptor trafficking. PLoS Comput Biol. 2018;14(5).
7. Williams A, Barry B. Penetration enhancers. Adv Drug Deliv Rev. 2012;64(5):128-18.
8. Ng L, Gupta M. Transdermal drug delivery systems in diabetes management: A review. Asian J Pharm Sci. 2020;15(1):13-25.
9. Gupta J, Thakur A, Thakur S. Transdermal drug delivery system of Metformin Hydrogen Chloride using Two Different Polymeric Combinations. Int J Heal Biol Sci. 2019;2(4):1-5
10. Danby S. Biological Variation in Skin Barrier Function: From A (Atopic Dermatitis) to X (Xerosis). Curr Probl Dermatol. 2016;49:47-60
11. Menon G. New insights into skin structure: scratching the surface. Adv Drug Deliv Rev. 2002;54(1):3-17.
12. Benson H, Watkinson A. . Topical and Transdermal Drug Delivery: Principles and Practice. 2012.
13. Suh H, Shin J, Kim Y. Microneedle Patches for Vaccine Delivery. Clin Exp Vaccine Res. 2014;3(1):42-9.
14. Walters K. . Dermatological and Transdermal Formulations. 2002.
15. Alexander A, Dwivedi S, Giri T, Saraf S, Saraf S, Tripathi D. Approaches for Breaking the Barriers of Drug Permeation through Transdermal Drug Delivery. J Control Release. 2012;164(1):26-40.
16. Wilson R, Waugh A, Grant A. . Anatomy and physiology in health and illness. 9th Edn. . 2001.
17. Kumar D, Sharma N, Rana A, Agarwal G, Bhat ZA. A review: transdermal drug delivery system: tools for novel drug delivery system. Int J Drug Dev Res. 2011;3(3):70-84.
18. Schuetz Y, Naik A, Guy R, Kalia Y. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin Drug Deliv. 2005;2(3):533-48.
19. Schoellhammer C, Blankschtein D, Langer R. Skin Permeabilization for Transdermal Drug Delivery: Recent Advances and Future Prospects. Expert Opin Drug Deliv. 2014;11(3):393-407.
20. Hwang I, Kim HN, Seong M, Lee S, Kang M, Yi H. Multifunctional Smart Skin Adhesive Patches for Advanced Health Care. Adv Health Mater. 2018;7(15).
21. Saroha K, Yadav B, Sharma B. Transdermal patch: A discrete dosage form. Int J Curr Pharm Res. 2011;3(3):98-108.
22. Jain N. Transdermal Drug Delivery. Introduction To Novel Drug Delivery System.
23. Ghosh S, Das S, Singh A, Gupta S. Applicability Of Natural Polymer And Natural Permeation Enhancer In Transdermal Drug Delivery System: A Detailed Review. Int J Innov Pharm Sci Res. 2021;9(8):1-24
24. Banerjee S, Chattopadhyay P, Ghosh A, Datta P, Veer V. Aspect of adhesives in transdermal drug delivery systems. Int J Adhes Adhes. 2014;50:70-8.4.
25. Berner B, John V. Pharmacokinetic characterization of transdermal delivery system. J Clin Pharmacol. 1994;26(2):121-34.
26. Imani M, Lahooti-Fard F, Taghizadeh SM, Takrousta M. Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system. AAPS Pharm Sci Tech. 2010;11(3):1268-75.
27. Dhiman S, Singh T, Rehni A. Transdermal patches: A recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011;3:26-34.
28. Stevenson C, Santini J, Langer R. Reservoir-based drug delivery systems utilizing microtechnology. Adv Drug Deliv Rev. 2012;64(14):1590-602.
29. Hughes PJ, Freeman MK, Wensel TM. Appropriate use of transdermal drug delivery systems. J Nurs Edu Pract. 2013;3(10):129-38.
30. Patel R, Baria A. Formulation and evaluation consideration of transdermal drug delivery system. Int J Pharm Res. 2011;3(1):1-9.
31. Sozio P, Cerasa L, Marinelli L, Stefano AD. Transdermal donepezil on the treatment of Alzheimer’s disease. Neuropsychiatr Dis Treat. 2012;8:361-8.
32. Singh J, Tripathi K, Sakia T. Effect of penetration enhancers on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev Ind Pharm. 1993;19:1623-8.
33. Wade A, Weller P. . Handbook of pharmaceutical Excipients. 1994.
34. Sankar V, Johnson DB, Sivanand V, Ravichandran V, Raghuraman S, Velrajan G. Design and Evaluation of Nifedipine Transdermal Patch. Indian J Pharm Sci. 2003;65(5):510-5.
35. Sood A, Panchagnula R. Role of Dissolution Studies in Controlled Release Drug Delivery System. STP Pharma Sci. 1999;9:157-68.